Facing the Pandemic of Antimicrobial Resistance: Current Actions and Future Challenges in Antibiotic Stewardship, Access, and Innovation in Brazil

  19 May 2023

While some high-income countries are considering specific actions to address the growing burden of antimicrobial resistance (AMR), efforts among low- and middle-income countries are less common. This case study analyzes current efforts in Brazil, a middle-income country, to improve antibiotic stewardship, access, and innovation.

We carried out a desk review of current active efforts, national policies, and procurement processes within the Brazilian Unified Health System (SUS) related to antibiotic access, stewardship, and innovation. We complemented this analysis with 11 expert interviews. All interviewees are currently working within the Brazilian health sector and have direct knowledge of and/or decision-making authority on AMR-related initiatives.

Our desk review and interviews highlighted the importance of three institutions. First, ANVISA, the national health regulatory authority, oversees new drug approvals and is responsible for health surveillance. Second, the Drug Market Regulation Chamber (CMED) regulates drug pricing in Brazil. And third, the Ministry of Health (MoH) manages public health policies and purchases highly specialized health products for SUS.

Author(s): Claudio A. Mora-García, Juliana Alberti, Javier Guzman, Anthony McDonnell, Morgan Pincombe and Andrea M. Prado
Effective Surveillance   Smart Innovations  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

Bangalore Bioinnovation Centre

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Every two weeks in your inbox

Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!

Subscribe

What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!

Keep me informed